BioCentury | Nov 18, 2013
Company News

Eisai sales and marketing update

...Eisai launched 5 and 10 mg Aciphex Sprinkle delayed-release rabeprazole capsules in the U.S. to treat gastroesophageal reflux...
BioCentury | Apr 8, 2013
Clinical News

Aciphex Sprinkle delayed-release rabeprazole regulatory update

...FDA approved 5 and 10 mg Aciphex Sprinkle delayed-release rabeprazole capsules treat gastroesophageal reflux disease (GERD) for up...
...& Johnson (NYSE:JNJ, New Brunswick, N.J.). Eisai Co. Ltd. (Tokyo:4523; Osaka:4523), Tokyo, Japan Product: Aciphex Sprinkle delayed-release rabeprazole...
BioCentury | Jan 7, 2013
Finance

Buyside View XXI: Sunny side up

Stephen Hansen Senior Writer A strong crop of early PDUFA dates and a sense that FDA is more navigable have given money managers in the U.S. and Europe a positive outlook for 2013, which they...
Items per page:
1 - 3 of 3